• Boryung will hold an extraordinary shareholders’ meeting in Seoul on Oct. 28, 2026.
• Shareholders will vote on approval of a plan to split off the prescription-drug sales business into a new wholly owned unit, Boryung Pharma Solution.
• The meeting will also vote on a plan to dispose of 1,774,000 treasury shares for employee compensation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boryung Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261013000298), on October 13, 2026, and is solely responsible for the information contained therein.